Paradigm
PrivateLast Round
Series B
Dec 4, 2025
Total Funding Raised
$281M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Paradigm Health is a healthcare technology company that provides an AI-powered clinical trial platform to connect biopharmaceutical sponsors with healthcare providers to streamline clinical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Data Integration, Compliance, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradigm Comparables
Compare Paradigm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IgniteData | 83% | |
| OpenClinica | 78% | |
| Flat Iron | 78% |
Paradigm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 4, 2025 | ||||
| Series A | Jan 25, 2023 |
Key People
Founding team and executive leadership
Paradigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Series B |
| ARCH Venture Partners | Series B |
| F-Prime Capital | Series A, Series B |
| Magnetic Ventures | Series A |
| BrightEdge | Series B, Series A |
| Lux Capital | Series A, Series B |
| ARCH Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Partnered with the U.S. Food and Drug Administration to test a new data system.
- Dec 4, 2025
$78M Series B round completed.
Paradigm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Paradigm's valuation, stock price, and market status.
Is Paradigm a public or private company?
Paradigm is a private company.
What is the current stock price of Paradigm?
Paradigm is a private company with no public stock price. No recent secondary market data is available.
How much is Paradigm worth (valuation)?
Valuation information for Paradigm is not publicly available.
Can I buy Paradigm stock?
Paradigm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Paradigm's last funding round?
Paradigm's most recent funding round was Series B on December 4, 2025.
Who are the main investors in Paradigm?
Key investors in Paradigm include ARCH Venture Partners, ARCH Venture Partners, General Catalyst.
Will Paradigm IPO soon?
No public IPO plans have been announced for Paradigm.
How can I track Paradigm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paradigm's secondary market activity and sign up for updates.